Intention to Re-Domicile

1 June 2012

Phorm, Inc. ('Phorm' or 'the Company')

Intention to Re-Domicile

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, announces its intention to re-domicile the holding company of the group from Delaware to Singapore. This will simplify the settlement mechanics relating to the trading in the Company's shares under the symbol PHRM by removing the requirement for certificated settlement of shares and allowing them to be traded electronically in CREST. The Directors believe this will provide significant assistance to the shares' liquidity. Further information relating to the proposed re-domicile will be provided at the Company's up coming AGM on 19 June 2012.

For Enquiries

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

- ends -

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com